MicrobiologybioRxivPreprint
DDU384: A new preclinical candidate for the treatment of Tuberculosis
Simon R. Green, Kirsteen I. Buchanan, Helena I. Boshoff…·Laura A. T. Cleghorn
This paper identifies DDU384, a new compound with potent in vivo efficacy against tuberculosis in murine models, showing potential to improve current treatment options.
DOI 10.64898/2026.10.26.760366